Beacon Pharmaceuticals Cash Flow Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Net Income	570.05	521.01	509.84	935.04	863.17	380.69
Depreciation & Amortization	527.78	527.78	518.92	439.7	385.16	511.01
Loss (Gain) From Sale of Assets	6.5	6.5	-3.07	-	-	-
Other Operating Activities	2,252	287.23	-147.1	438.72	75.87	-243.62
Change in Accounts Receivable	-767.59	-767.59	-251.01	-30.72	-873.78	-357.19
Change in Inventory	-895.97	-895.97	-19.73	-693.28	-246.07	-28.33
Change in Accounts Payable	680.87	680.87	191.87	-7.83	183.53	-8.58
Change in Income Taxes	-	-	-	-169.84	162.23	-64.93
Change in Other Net Operating Assets	-539.46	-539.46	-178.55	170.39	-353.56	102.09
Operating Cash Flow	1,834	-179.63	621.18	1,082	196.56	291.14
Operating Cash Flow Growth	-	-	-42.60%	450.56%	-32.49%	32.08%
Capital Expenditures	-318.69	-1,095	-1,814	-1,719	-313.41	-313.94
Sale of Property, Plant & Equipment	30.29	30.15	-	-	-	-
Sale (Purchase) of Intangibles	-25.22	-25.22	-	-	-	-
Investment in Securities	-1,936	-1,276	-2,190	-118.52	-403.71	-0.82
Other Investing Activities	-7.26	-0	39.83	-	3.24	1.31
Investing Cash Flow	-2,257	-2,366	-3,965	-1,838	-713.87	-313.46
Short-Term Debt Issued	-	-	-	1,529	349.06	473.1
Long-Term Debt Issued	-	2,864	3,628	-	-	-
Total Debt Issued	702.26	2,864	3,628	1,529	349.06	473.1
Long-Term Debt Repaid	-	-	-	-199.71	-33.27	-76.68
Total Debt Repaid	-252.18	-	-	-199.71	-33.27	-76.68
Net Debt Issued (Repaid)	450.08	2,864	3,628	1,330	315.79	396.43
Common Dividends Paid	-739.32	-369.56	-371.06	-373.53	-59.42	-57.99
Financing Cash Flow	-289.24	2,494	3,257	956.25	256.37	338.44
Foreign Exchange Rate Adjustments	-147.17	-93.69	-	-	-	-
Miscellaneous Cash Flow Adjustments	0	-	-	-	-	-
Net Cash Flow	-859.36	-145.24	-86.31	200.66	-260.94	316.13
Free Cash Flow	1,516	-1,275	-1,193	-637.07	-116.85	-22.8
Free Cash Flow Margin	13.09%	-11.91%	-14.02%	-7.94%	-1.64%	-0.41%
Free Cash Flow Per Share	6.56	-5.52	-5.17	-2.76	-0.51	-0.10
Cash Interest Paid	1,211	983.91	464.36	339.38	166.8	150.27
Cash Income Tax Paid	476.43	257.56	271.77	450.75	17.31	20
Levered Free Cash Flow	1,788	-3,102	-3,814	-1,146	-562.04	-229.56
Unlevered Free Cash Flow	2,590	-2,475	-3,526	-934.37	-459.03	-136.24
Change in Working Capital	-1,522	-1,522	-257.42	-731.28	-1,128	-356.94

Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.